Table2_Adverse event profile differences between pralsetinib and selpercatinib: a real-world study based on the FDA adverse events reporting system.docx
Aims<p>The objective of this study is to compare the adverse events (AEs) associated with pralsetinib and selpercatinib.</p>Methods<p>To evaluate the imbalance of AEs linked to pralsetinib and selpercatinib in real-world data, the reporting odds ratio (ROR) was utilized to detect p...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , |
| Published: |
2024
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|